On July 8, 2025, we delivered the first batch of Smecta® Oral Rehydration Salts III in China, partnering with Jilin Sihuan Pharmaceutical. This is not only the market debut of a new product but also a milestone in our localization journey, bringing innovative and accessible intestinal health solutions to Chinese families. 💪❤️

As Desmond TAN, Mayoly China General Manager, shared: “It’s a pivotal move to continually build globally leading intestinal health solutions in China.” Together with our partners, we’re strengthening our shared vision of wellness and turning such vision into tangible health benefits for our customers and patients — excited for what’s next! 🚀

No comments yet, be the first to comment.

发表回复